PMID- 15452235 OWN - NLM STAT- MEDLINE DCOM- 20041102 LR - 20181113 IS - 0022-538X (Print) IS - 1098-5514 (Electronic) IS - 0022-538X (Linking) VI - 78 IP - 20 DP - 2004 Oct TI - Papillomavirus-like particles stimulate murine bone marrow-derived dendritic cells to produce alpha interferon and Th1 immune responses via MyD88. PG - 11152-60 AB - Dendritic cells (DCs) link innate and adaptive immunity by sensing pathogens or vaccinogens and signaling a variety of defense responses. Since human papillomavirus type 16 L1 virus-like particles (HPV16 VLPs) induce a potent, protective immune response after vaccination, we examined their recognition by DCs. HPV16 VLPs cause phenotypic maturation of murine bone marrow-derived DCs (BMDCs), and immunization of mice with HPV16 VLP-loaded BMDCs or HPV16 VLPs alone induced T helper 1 (Th1)-biased immune responses. Analysis of transcriptional responses of murine BMDCs by microarray suggested that alpha/beta interferon (IFN-alpha/beta) transcripts and numerous proinflammatory cytokines and chemokines are up regulated in response to HPV16 VLPs. Indeed, the induction of IFN-alpha, IFN-gamma, and interleukin-12 (IL-12) production by BMDCs after stimulation with HPV16 VLPs was demonstrated by quantitative enzyme-linked immunosorbent assay. Many microbial products that induce proinflammatory responses are recognized via Toll-like receptor (TLR) signaling through the key adaptor protein MyD88 and activation of NF-kappaB, nuclear factor of activated T cells (NF-AT), and activating protein 1 (AP-1). Reporter assays indicated that HPV16 VLPs activated NF-kappaB-, NF-AT-, and AP-1-dependent transcription in the RAW264.7 macrophage cell line. Knockdown of MyD88 transcripts by small interfering RNA in the RAW264.7 macrophage cell line inhibited the activation of NF-kappaB-, NF-AT- and AP-1-dependent transcription by HPV16 VLP. Furthermore, MyD88(-/-) BMDCs failed to up regulate IL-12 and IFN-alpha and -gamma in response to HPV16 VLPs. Finally, Th1-biased immune responses to HPV16 VLPs are dramatically impaired in MyD88 and IFN-alpha/beta receptor-deficient mice. This implicates TLR recognition as central to immune recognition of HPV16 L1 VLPs. FAU - Yang, Rongcun AU - Yang R AD - Department of Pathology, Johns Hopkins School of Medicine, Ross 512B, 720 Rutland Avenue, Baltimore, MD 21205, USA. FAU - Murillo, Francisco Martinez AU - Murillo FM FAU - Cui, Hengmi AU - Cui H FAU - Blosser, Richard AU - Blosser R FAU - Uematsu, Satoshi AU - Uematsu S FAU - Takeda, Kiyoshi AU - Takeda K FAU - Akira, Shizuo AU - Akira S FAU - Viscidi, Raphael P AU - Viscidi RP FAU - Roden, Richard B S AU - Roden RB LA - eng GR - P01 AI048203/AI/NIAID NIH HHS/United States GR - P50 CA098252/CA/NCI NIH HHS/United States GR - P01 AI 48203/AI/NIAID NIH HHS/United States GR - P50 CA 098252/CA/NCI NIH HHS/United States PT - Journal Article PT - Research Support, Non-U.S. Gov't PT - Research Support, U.S. Gov't, P.H.S. PL - United States TA - J Virol JT - Journal of virology JID - 0113724 RN - 0 (Adaptor Proteins, Signal Transducing) RN - 0 (Antigens, Differentiation) RN - 0 (Interferon-alpha) RN - 0 (MYD88 protein, human) RN - 0 (Myd88 protein, mouse) RN - 0 (Myeloid Differentiation Factor 88) RN - 0 (Receptors, Immunologic) RN - 187348-17-0 (Interleukin-12) RN - 82115-62-6 (Interferon-gamma) SB - IM MH - Adaptor Proteins, Signal Transducing MH - Animals MH - Antigens, Differentiation/genetics/*metabolism MH - Bone Marrow/immunology MH - Cell Differentiation MH - Cell Line MH - Dendritic Cells/*immunology/metabolism/virology MH - Immunization MH - Interferon-alpha/*metabolism MH - Interferon-gamma/metabolism MH - Interleukin-12/metabolism MH - Male MH - Mice MH - Mice, Inbred C57BL MH - Myeloid Differentiation Factor 88 MH - Papillomaviridae/*immunology/pathogenicity MH - Receptors, Immunologic/genetics/*metabolism MH - Th1 Cells/*immunology MH - Up-Regulation MH - Virion/*immunology PMC - PMC521855 EDAT- 2004/09/29 05:00 MHDA- 2004/11/04 09:00 PMCR- 2004/10/01 CRDT- 2004/09/29 05:00 PHST- 2004/09/29 05:00 [pubmed] PHST- 2004/11/04 09:00 [medline] PHST- 2004/09/29 05:00 [entrez] PHST- 2004/10/01 00:00 [pmc-release] AID - 78/20/11152 [pii] AID - 1145-04 [pii] AID - 10.1128/JVI.78.20.11152-11160.2004 [doi] PST - ppublish SO - J Virol. 2004 Oct;78(20):11152-60. doi: 10.1128/JVI.78.20.11152-11160.2004.